Publikationen in Zusammenarbeit mit Forschern von University of California, San Francisco (4)

2015

  1. The position of strontium ranelate in today’s management of osteoporosis

    Osteoporosis International, Vol. 26, Núm. 6, pp. 1667-1671

2014

  1. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment

    The Lancet Diabetes and Endocrinology, Vol. 2, Núm. 8, pp. 634-647

2004

  1. Continuing outcomes relevant to Evista: Breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene

    Journal of the National Cancer Institute, Vol. 96, Núm. 23, pp. 1751-1761

  2. The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis

    New England Journal of Medicine, Vol. 350, Núm. 5, pp. 459-468